Drug-polymer solubility and miscibility: Stability consideration and practical challenges in amorphous solid dispersion development.

Drug-polymer solid dispersion has been demonstrated as a feasible approach to formulate poorly water-soluble drugs in the amorphous form, for the enhancement of dissolution rate and bioperformance. The solubility (for crystalline drug) and miscibility (for amorphous drug) in the polymer are directly related to the stabilization of amorphous drug against crystallization. Therefore, it is important for pharmaceutical scientists to rationally assess solubility and miscibility in order to select the optimal formulation (e.g., polymer type, drug loading, etc.) and recommend storage conditions, with respect to maximizing the physical stability. This commentary attempts to discuss the concepts and implications of the drug-polymer solubility and miscibility on the stabilization of solid dispersions, review recent literatures, and propose some practical strategies for the evaluation and development of such systems utilizing a working diagram.

[1]  Bruno C. Hancock,et al.  Disordered drug delivery: destiny, dynamics and the Deborah number , 2002, The Journal of pharmacy and pharmacology.

[2]  Lynne S. Taylor,et al.  Spectroscopic Characterization of Interactions Between PVP and Indomethacin in Amorphous Molecular Dispersions , 1997, Pharmaceutical Research.

[3]  L Yu,et al.  Amorphous pharmaceutical solids: preparation, characterization and stabilization. , 2001, Advanced drug delivery reviews.

[4]  W R Porter,et al.  Physicochemical considerations in the preparation of amorphous ritonavir-poly(ethylene glycol) 8000 solid dispersions. , 2001, Journal of pharmaceutical sciences.

[5]  K. Sekiguchi,et al.  STUDIES ON ABSORPTION OF EUTECTIC MIXTURE. II. ABSORPTION OF FUSED CONGLOMERATES OF CHLORAMPHENICOL AND UREA IN RABBITS. , 1964, Chemical & pharmaceutical bulletin.

[6]  C. Angell,et al.  The Glass Transition of Water, Based on Hyperquenching Experiments , 2001, Science.

[7]  R. Koningsveld.  Liquid-liquid equilibria in multicomponent polymer systems , 1970 .

[8]  Bruno C. Hancock,et al.  Molecular Mobility of Amorphous Pharmaceutical Solids Below Their Glass Transition Temperatures , 1995, Pharmaceutical Research.

[9]  D. Fatouros,et al.  Clinical studies with oral lipid based formulations of poorly soluble compounds , 2007, Therapeutics and clinical risk management.

[10]  Sumie Yoshioka,et al.  Miscibility of nifedipine and hydrophilic polymers as measured by (1)H-NMR spin-lattice relaxation. , 2007, Chemical & pharmaceutical bulletin.

[11]  A. N. Campbell,et al.  Concentrations, Total and Partial Vapor Pressures, Surface Tensions and Viscosities, in the Systems Phenol—Water and Phenol—Water—4% Succinic Acid , 1937 .

[12]  Bruno C. Hancock,et al.  Characteristics and significance of the amorphous state in pharmaceutical systems. , 1997, Journal of pharmaceutical sciences.

[13]  Zeren Wang,et al.  A Mechanistic Investigation of An Amorphous Pharmaceutical and Its Solid Dispersions, Part II: Molecular Mobility and Activation Thermodynamic Parameters , 2004, Pharmaceutical Research.

[14]  J Dressman,et al.  Improving drug solubility for oral delivery using solid dispersions. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[15]  C. Angell,et al.  Formation of Glasses from Liquids and Biopolymers , 1995, Science.

[16]  A. J. Staverman,et al.  Liquid-liquid phase separation in multicomponent polymer solutions , 1967 .

[17]  R. Koningsveld,et al.  Liquid–liquid phase separation in multicomponent polymer solutions. IX. Concentration‐dependent pair interaction parameter from critical miscibility data on the system polystyrene–cyclohexane , 1970 .

[18]  P. Flory.  Thermodynamics of High Polymer Solutions , 1941 .

[19]  J. Tao,et al.  Mechanistic Investigation of Pluronic® Based Nano-crystalline Drug-polymer Solid Dispersions , 2007, Pharmaceutical Research.

[20]  P. Gao,et al.  Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs , 2006, Expert opinion on drug delivery.

[21]  Michael A Repka,et al.  Applications of hot-melt extrusion for drug delivery , 2008, Expert opinion on drug delivery.

[22]  D. H. Lewis,et al.  Multiple-sample probe for solid-state NMR studies of pharmaceuticals. , 2006, Solid state nuclear magnetic resonance.

[23]  S. L. Winslow,et al.  Solid-state NMR studies of pharmaceutical solids in polymer matrices , 2004, Analytical and bioanalytical chemistry.

[24]  Yatindra Joshi,et al.  Phase Behavior of Amorphous Molecular Dispersions I: Determination of the Degree and Mechanism of Solid Solubility , 2004, Pharmaceutical Research.

[25]  Patrick J. Marsac,et al.  Estimation of Drug–Polymer Miscibility and Solubility in Amorphous Solid Dispersions Using Experimentally Determined Interaction Parameters , 2008, Pharmaceutical Research.

[26]  Simon Bates,et al.  Evaluation of Drug-Polymer Miscibility in Amorphous Solid Dispersion Systems , 2009, Pharmaceutical Research.

[27]  K. Marsh,et al.  Enhancing the bioavailability of ABT-963 using solid dispersion containing Pluronic F-68. , 2004, International journal of pharmaceutics.

[28]  Lian Yu,et al.  Solubility of Small-Molecule Crystals in Polymers: d-Mannitol in PVP, Indomethacin in PVP/VA, and Nifedipine in PVP/VA , 2009, Pharmaceutical Research.

[29]  Lynne S. Taylor,et al.  Effects of Polymer Type and Storage Relative Humidity on the Kinetics of Felodipine Crystallization from Amorphous Solid Dispersions , 2009, Pharmaceutical Research.

[30]  Zeren Wang,et al.  A Mechanistic Investigation of an Amorphous Pharmaceutical and Its Solid Dispersions, Part I: A Comparative Analysis by Thermally Stimulated Depolarization Current and Differential Scanning Calorimetry , 2004, Pharmaceutical Research.

[31]  Keiji Sekiguchi,et al.  Studies on Absorption of Eutectic Mixture. I. A Comparison of the Behavior of Eutectic Mixture of Sulfathiazole and that of Ordinary Sulfathiazole in Man. , 1961 .

[32]  Simon Bates,et al.  Characterization of amorphous API:Polymer mixtures using X-ray powder diffraction. , 2008, Journal of pharmaceutical sciences.

[33]  Patrick J. Marsac,et al.  Theoretical and Practical Approaches for Prediction of Drug–Polymer Miscibility and Solubility , 2006, Pharmaceutical Research.

[34]  James S. Taylor,et al.  Ideal copolymers and the second‐order transitions of synthetic rubbers. i. non‐crystalline copolymers , 2007 .

[35]  Yatindra Joshi,et al.  Phase Behavior of Amorphous Molecular Dispersions II: Role of Hydrogen Bonding in Solid Solubility and Phase Separation Kinetics , 2005, Pharmaceutical Research.

[36]  R. T. Berendt,et al.  Solid-state NMR spectroscopy in pharmaceutical research and analysis , 2006 .

[37]  M. Huggins.  THERMODYNAMIC PROPERTIES OF SOLUTIONS OF LONG‐CHAIN COMPOUNDS , 1942 .

[38]  P. Arnaud,et al.  In vitro and in vivo evaluation of carbamazepine-PEG 6000 solid dispersions. , 2001, International journal of pharmaceutics.

[39]  Simon Bates,et al.  Novel methods for the assessment of miscibility of amorphous drug-polymer dispersions. , 2009, Journal of pharmaceutical sciences.

[40]  Isidor Kirshenbaum,et al.  The Vapor Pressure and Heat of Vaporization of N15 , 1941 .

[41]  Patrick J. Marsac,et al.  Recrystallization of Nifedipine and Felodipine from Amorphous Molecular Level Solid Dispersions Containing Poly(vinylpyrrolidone) and Sorbed Water , 2008, Pharmaceutical Research.

[42]  R. Pignatello,et al.  Molecular Properties of Ibuprofen and Its Solid Dispersions with Eudragit RL100 Studied by Solid-State Nuclear Magnetic Resonance , 2005, Pharmaceutical Research.

[43]  G. Zografi,et al.  Water vapor absorption into amorphous hydrophobic drug/poly(vinylpyrrolidone) dispersions. , 2002, Journal of pharmaceutical sciences.